tiprankstipranks
Trending News
More News >
Manulife Financial Corp (TSE:MFC)
TSX:MFC

Manulife Financial (MFC) AI Stock Analysis

Compare
2,110 Followers

Top Page

TSE:MFC

Manulife Financial

(TSX:MFC)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
C$49.00
â–²(5.22% Upside)
Action:ReiteratedDate:03/13/26
The score is driven primarily by solid improving fundamentals and generally controlled leverage, supported by reasonable valuation and a strong dividend. These positives are tempered by weak near-term technical momentum and identified stability risks (2025 margin compression, uneven cash-flow quality signals, US segment volatility, and late-2025 wealth net outflows).
Positive Factors
Sustained revenue rebound
A multiyear rebound in revenue through 2023–2025 indicates durable demand across insurance, wealth and asset-management lines. Sustained top-line recovery supports fee growth, underwriting scale and reinvestment capacity, improving the company’s ability to fund long-duration liabilities and steady earnings over the next 2–6 months and beyond.
Controlled balance-sheet leverage
Debt-to-equity in the ~0.20–0.29 range is conservative for a large life insurer and signals healthy capitalization. This structural strength preserves regulatory and financial flexibility to absorb shocks, underwrite new business, and support dividends or buybacks without forcing asset sales, helping sustain operations across economic cycles.
Improving cash generation
Rising operating and free cash flow through 2025 demonstrates improving conversion of earnings into distributable capital. Durable cash generation underpins reinvestment in growth, supports capital returns and strengthens the general account funding of liabilities, reducing reliance on external financing over the medium term.
Negative Factors
Margin compression in 2025
Observed margin deterioration in 2025 suggests adverse product mix, rising expense load, or tougher underwriting/investment conditions. Persistent margin pressure would erode operating leverage and long-term ROE, forcing higher pricing, cost cuts or capital consumption to restore profitability, which weakens durable earnings quality.
US segment earnings volatility & wealth outflows
Volatility in the US (John Hancock) earnings and net outflows in wealth management threaten fee-based revenue stability. Given the sizeable US and wealth businesses, sustained flow volatility would reduce recurring fees and increase earnings variability, complicating multi-quarter planning and pressuring long-term growth assumptions.
Inconsistent cash-flow quality
Irregular conversion between accounting profit and cash flow reduces predictability of distributable capital and capital planning. For an insurer, uneven cash quality can constrain dividend sustainability or buybacks and necessitate larger capital buffers, limiting the firm’s ability to deploy capital consistently in adverse conditions.

Manulife Financial (MFC) vs. iShares MSCI Canada ETF (EWC)

Manulife Financial Business Overview & Revenue Model

Company DescriptionManulife Financial Corporation, together with its subsidiaries, provides financial products and services in Asia, Canada, the United States, and internationally. The company operates through Wealth and Asset Management Businesses; Insurance and Annuity Products; And Corporate and Other segments. The Wealth and Asset Management Businesses segment provides mutual funds and exchange-traded funds, group retirement and savings products, and institutional asset management services through agents and brokers affiliated with the company, securities brokerage firms, and financial advisors pension plan consultants and banks. The Insurance and Annuity Products segment offers deposit and credit products; individual life, and individual and group long-term care insurance; and guaranteed and partially guaranteed annuity products through insurance agents, brokers, banks, financial planners, and direct marketing. The Corporate and Other segment is involved in property and casualty insurance and reinsurance businesses; and run-off reinsurance operations, including variable annuities, and accident and health. It also manages timberland and agricultural portfolios; and engages in insurance agency, portfolio and mutual fund management, mutual fund dealer, life, annuity, long-term care, and financial reinsurance; and fund management businesses. Additionally, the company holds and manages provides investment management, counseling, advisory, and dealer services. Manulife Financial Corporation was incorporated in 1887 and is headquartered in Toronto, Canada.
How the Company Makes MoneyManulife makes money primarily through a combination of (1) insurance underwriting and policy-related income, (2) investment income on assets it manages (both for its own general account and for customers), and (3) fee-based revenue from wealth and asset management. 1) Insurance premiums and underwriting results: In its insurance businesses, Manulife collects premiums from policyholders for life, health, and other protection products. Over time it pays claims and benefits and incurs operating expenses; the profitability of this spread (premiums and other policy charges versus claims, benefits, expenses, and changes in actuarial reserves) contributes to earnings. Product design and pricing (e.g., mortality/morbidity assumptions, lapse behavior, expenses), reinsurance usage, and experience relative to assumptions influence underwriting profitability. 2) Net investment income and returns on invested assets: Manulife invests the assets backing its insurance liabilities (its general account) largely in fixed income and other assets. Earnings are driven by interest income, dividends, realized gains/losses, and changes in fair value where applicable, net of credit losses and investment expenses. The level and shape of interest rates, credit spreads, equity markets (for certain products), and policyholder behavior affect results. Investment performance also matters for products with policyholder account values (e.g., segregated fund/variable products and certain annuities), where Manulife may earn fees but can also have market-related exposures depending on product features and hedging. 3) Wealth and asset management fees: Through its global wealth and asset management operations (including brand operations such as Manulife Investment Management and John Hancock Investment Management in the U.S.), Manulife earns management fees and other service fees based on assets under management (AUM) or assets under administration (AUA). These fees may come from mutual funds, managed accounts, retirement plan services, and institutional mandates. Revenue typically rises with higher AUM driven by market appreciation and net inflows, and declines when markets fall or clients redeem assets. 4) Retirement and group businesses: In group insurance and retirement/benefits administration, Manulife earns premiums, administrative fees, and (where it provides investment options) investment management fees. Profitability depends on claims experience, pricing discipline, persistency, and cost control, as well as the competitiveness of distribution relationships (employer plans, advisors, and institutional channels). 5) Distribution and other factors that support earnings: Manulife distributes products through multiple channels such as captive and independent advisors, brokers, banks, and institutional relationships. Scale, brand strength (including John Hancock in the U.S.), and long-duration customer relationships can support recurring premium flows and fee revenue. If specific major partnership revenue contributions are required, null.

Manulife Financial Earnings Call Summary

Earnings Call Date:Nov 12, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong growth in APE sales, positive net flows in Global WAM, and a strategic acquisition. However, it also noted challenges such as unfavorable U.S. mortality experience and elevated credit loss provisions. The sentiment is balanced with optimism for future growth and strategic alignment.
Q3-2025 Updates
Positive Updates
Strong Business Growth
APE sales increased 15% from the prior year with more than 30% growth in both Asia and the U.S. Strong sales supported significant growth in value metrics with 37% growth in new business CSM and 20% growth in new business value.
Positive Net Flows in Global WAM
Global WAM delivered positive net flows of nearly $1 billion, demonstrating the strength of its diversified platform.
Acquisition of Comvest Credit Partners
Manulife announced the acquisition of a 75% stake in Comvest Credit Partners for USD 937.5 million, expected to be immediately accretive to core EPS, core ROE, and core EBITDA margin.
Strong Capital Position
The LICAT capital ratio remained strong at 136% and the financial leverage ratio was 23.6%, continuing to stay well below the 25% medium-term target.
Continued Growth in Asia
Asia's APE increased 31% from the prior year, with substantial growth in Hong Kong, Mainland China, and Singapore.
Negative Updates
Unfavorable U.S. Mortality Experience
The U.S. segment's core earnings decreased by 53% from the prior year due to unfavorable mortality experience in the life business.
Elevated Expected Credit Loss Provision
The net investment result was impacted by a net charge in the expected credit loss provision, primarily related to certain below-investment-grade loan investments in the U.S.
Impact of eMPF Transition
The transition to the new eMPF platform in Hong Kong is expected to have a full quarterly run rate impact of approximately USD 25 million beginning in the first quarter of 2026.
Decline in U.S. Core Earnings
U.S. core earnings decreased due to unfavorable mortality experience, lower investment spreads, and strengthened ECL provisions.
Company Guidance
During the Manulife Financial second quarter 2025 earnings call, several key metrics and strategic updates were highlighted. The company announced its acquisition of a 75% stake in Comvest Credit Partners for USD 937.5 million, which is expected to be immediately accretive to core earnings per share (EPS), core return on equity (ROE), and core EBITDA margin. The acquisition will scale Manulife's private markets business, enhancing its private credit capabilities with Comvest's USD 14.7 billion platform. Manulife's LICAT ratio is expected to decrease by less than 3 percentage points due to the acquisition but remains strong at 136%. The second quarter results showed continued top-line growth, with insurance segments generating over 30% growth in new business contractual service margin (CSM) and 2% growth in core EPS from the previous year. However, profitability was affected by elevated U.S. mortality and a provision in expected credit loss, with core EPS growth normalizing to 7% when excluding the latter. The U.S. business saw a 40% increase in annual premium equivalent (APE) sales despite core earnings decreasing due to unfavorable mortality experience and lower investment spreads. Overall, Manulife remains confident in achieving its 2027 targets, including an 18%+ ROE, supported by strong underlying business growth and strategic capital deployment.

Manulife Financial Financial Statement Overview

Summary
Financials show a clear post-2022 recovery with revenue growth sustained into 2024–2025 and normalized profitability (net margins ~11–13%). Balance-sheet leverage remains moderate for an insurer (D/E ~0.20–0.29) and ROE is generally healthy outside the 2022 loss year. Offsetting this, 2025 shows margin slippage and cash-flow quality signals are uneven/volatile in the provided history; KPIs also flag US segment earnings volatility and late-2025 net outflows in Wealth & Asset Management as risks to earnings stability.
Income Statement
74
Positive
Revenue rebounded strongly after the 2022 downturn, accelerating in 2023 and remaining positive in 2024–2025. Profitability has normalized with solid net margins around ~11–13% in 2023–2025 versus a loss in 2022, and operating profitability is consistently positive again. The main weakness is margin compression in 2025 versus 2024 (gross and operating margins down), suggesting a less favorable mix or higher costs despite higher revenue.
Balance Sheet
78
Positive
Leverage looks controlled for the business, with debt-to-equity staying in a fairly tight band (~0.20–0.29) across the period, and equity remaining sizable. Returns on equity are consistently healthy in most years (roughly ~10–12%) with the notable exception of 2022, when losses drove returns negative. A watch item is the upward drift in leverage since 2021 and the very large asset base typical of insurers, which can amplify sensitivity to market and credit conditions.
Cash Flow
72
Positive
Cash generation is strong and improving: operating cash flow and free cash flow rise from 2022 through 2025, with 2025 delivering a step-up versus 2024. Free cash flow is shown equal to net income each year, indicating steady conversion on the provided data. The weakness is volatility and inconsistency in the cash-flow-to-profit relationship (including unusually high or zero coverage readings in some years), which reduces confidence in year-to-year cash flow quality based solely on these figures.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue53.01B45.58B42.31B23.62B59.84B
Gross Profit13.53B15.11B13.68B1.00B25.27B
EBITDA6.79B7.26B6.59B-3.56B9.66B
Net Income5.78B5.63B5.46B-2.10B6.66B
Balance Sheet
Total Assets1.03T978.82B875.57B848.94B917.64B
Cash, Cash Equivalents and Short-Term Investments36.33B25.79B20.34B19.15B22.59B
Total Debt14.68B14.16B12.74B12.36B11.86B
Total Liabilities972.95B925.86B826.85B792.56B858.77B
Stockholders Equity50.96B51.54B47.30B46.80B58.41B
Cash Flow
Free Cash Flow32.10B26.49B20.42B16.63B23.16B
Operating Cash Flow32.10B26.49B20.42B16.63B23.16B
Investing Cash Flow-28.36B-18.46B-13.72B-18.40B-24.44B
Financing Cash Flow-2.05B-4.17B-5.04B-1.83B-2.05B

Manulife Financial Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price46.57
Price Trends
50DMA
49.39
Negative
100DMA
48.56
Negative
200DMA
45.25
Positive
Market Momentum
MACD
-0.86
Negative
RSI
45.07
Neutral
STOCH
80.27
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MFC, the sentiment is Neutral. The current price of 46.57 is below the 20-day moving average (MA) of 47.34, below the 50-day MA of 49.39, and above the 200-day MA of 45.25, indicating a neutral trend. The MACD of -0.86 indicates Negative momentum. The RSI at 45.07 is Neutral, neither overbought nor oversold. The STOCH value of 80.27 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:MFC.

Manulife Financial Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
C$40.63B13.4812.83%3.28%-9.03%44.14%
74
Outperform
C$44.02B15.1216.27%1.86%2.51%44.44%
69
Neutral
$47.61B12.8814.68%4.11%-19.88%-13.92%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
66
Neutral
$78.09B14.6811.34%3.49%5.46%10.52%
66
Neutral
C$50.85B8.5618.65%0.84%10.08%24.18%
65
Neutral
C$56.79B15.1813.98%3.62%-20.64%14.88%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:MFC
Manulife Financial
46.57
4.55
10.81%
TSE:SLF
Sun Life Financial
85.95
8.17
10.50%
TSE:FFH
Fairfax Financial Holdings
2,370.99
387.86
19.56%
TSE:GWO
Great-West Lifeco
62.82
11.93
23.44%
TSE:IFC
Intact Financial Corporation
247.89
-27.11
-9.86%
TSE:POW
Power Corp of Canada
63.83
15.22
31.31%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 13, 2026